Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients (Journal of the American College of Cardiology)
The abdomen is an FDA-approved injection site for these medications, offering accessibility and consistent subcutaneous tissue
While relationships were not as robust as for the matched-time analyses, fasting levels of 17 metabolites were positively correlated with glucose at 120 minutes, including lactate, AAs (Gln, Pro, Trp, Tyr, betaine), carnitine, and multiple lipids (lysophosphatidylcholine [LPC] 18:0, 18:2, 20:3, and 22:6
33 They found that the HR for developing wet AMD was 2.21 in GLP-1 RA users compared with controls
The Core Difference: Two Receptors vs Three Tirzepatide activates: GLP-1 receptor (appetite suppression, glucose control) GIP receptor (synergistic metabolic effects) Retatrutide activates: GLP-1 receptor GIP receptor Glucagon receptor (thermogenesis, direct fat oxidation) That third receptor is the key difference
Wegovy (semaglutide) tablets, for oral use
